{"adverse_reactions":["Sincerus Florida, LLC adverse reactions. v"],"components":["Active, inactive c"],"effective_time":"20190502","id":"87ed3aff-1a11-c070-e053-2a95a90af490","instructions_for_use":["Directions for use. C"],"openfda":{},"package_label_principal_display_panel":["NDC 72934-1153 NIACINAMIDE 2% / SPIRONOLACTONE 5% / TRETINOIN 0.05% Gel 30 gm. C"],"set_id":"87ed3aff-1a10-c070-e053-2a95a90af490","spl_product_data_elements":["NIACINAMIDE 2% / SPIRONOLACTONE 5% / TRETINOIN 0.05% NIACINAMIDE 2% / SPIRONOLACTONE 5% / TRETINOIN 0.05% NIACINAMIDE NIACINAMIDE TRETINOIN TRETINOIN SPIRONOLACTONE SPIRONOLACTONE"],"version":"1"}